Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Genentech
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Vanderbilt University
Information provided by (Responsible Party):
Daniel Cho, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00782275
First received: October 29, 2008
Last updated: August 16, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)